Papers
How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review
BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7492.625 (Published 17 March 2005) Cite this as: BMJ 2005;330:625
Related articles
- Editor's Choice Published: 17 March 2005; BMJ 330 doi:10.1136/bmj.330.7492.0-h
- This Week In The BMJ Published: 17 March 2005; BMJ 330 doi:10.1136/bmj.330.7492.0
- Editorial Published: 18 August 2005; BMJ 331 doi:10.1136/bmj.331.7514.415
- News Published: 15 March 2007; BMJ 334 doi:10.1136/bmj.39153.350174.DB
See more
- Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog findsBMJ November 13, 2024, 387 q2518; DOI: https://doi.org/10.1136/bmj.q2518
- Semaglutide’s CVD indication could cost US Medicare $145bn extra a yearBMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878
- Semaglutide: UK regulator approves drug for prevention of cardiovascular eventsBMJ July 25, 2024, 386 q1660; DOI: https://doi.org/10.1136/bmj.q1660
- Why India is failing to track heatstroke fatalities properlyBMJ July 17, 2024, 386 q1437; DOI: https://doi.org/10.1136/bmj.q1437
- Mail on Sunday articles that accused three commentators of being “statin deniers” were misinformed, judge rulesBMJ June 26, 2024, 385 q1424; DOI: https://doi.org/10.1136/bmj.q1424
Cited by...
- Association of Depression Symptoms and Biomarkers of Risk on Clinical Outcomes in HFrEF
- Opportunistic screening for asymptomatic left ventricular dysfunction in type 2 diabetes mellitus
- PRospective Evaluation of natriuretic peptide-based reFERral of patients with chronic heart failure in primary care (PREFER): a real-world study
- B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation
- Plasma haptoglobin level can augment NT-proBNP to predict poor outcome in patients with severe acute decompensated heart failure
- Guiding Heart Failure Therapy After GUIDE-IT: Back to the Drawing Board
- Does specialist review for patients with suspected heart failure predict better outcomes? An observational study on the utility of compliance with NICE guidelines
- Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides?
- Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)
- Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry
- Corticotropin releasing hormone receptor 2 exacerbates chronic cardiac dysfunction
- Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association
- Advances in heart failure: a review of biomarkers, emerging pharmacological therapies, durable mechanical support and telemonitoring
- Obesity Paradox: Comparison of Heart Failure Patients With and Without Comorbid Diabetes
- An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF)
- Established and Emerging Roles of Biomarkers in Heart Failure Clinical Trials
- Model Building as an Educational Hobby
- Comparing Sodium Intake Strategies in Heart Failure: Rationale and Design of the Prevent Adverse Outcomes in Heart Failure by Limiting Sodium (PROHIBIT) Study
- Exercise Limitation Associated With Asymptomatic Left Ventricular Impairment: Analogy With Stage B Heart Failure
- B-type natriuretic peptide-guided therapy for perioperative medicine?
- Head-to-Head Comparison of 2 Myocardial Fibrosis Biomarkers for Long-Term Heart Failure Risk Stratification: ST2 Versus Galectin-3
- Assessment of a multimarker strategy for prediction of mortality in older heart failure patients: a cohort study
- Are Serial BNP Measurements Useful in Heart Failure Management?: Serial Natriuretic Peptide Measurements Are Not Useful in Heart Failure Management: The Art of Medicine Remains Long
- N-terminal Pro-B-Type Natriuretic Peptide, Left Ventricular Mass, and Incident Heart Failure: Multi-Ethnic Study of Atherosclerosis
- Translational phases of evidence in a prognostic biomarker: a systematic review and meta-analysis of natriuretic peptides and the prognosis of stable coronary disease
- Infliximab Treatment Increases Left Ventricular Ejection Fraction in Patients with Rheumatoid Arthritis: Assessment of Heart Function by Echocardiography, Endothelin 1, Interleukin 6, and NT-pro Brain Natriuretic Peptide
- Galectin-3 in Ambulatory Patients With Heart Failure: Results From the HF-ACTION Study
- Human Pro-B-Type Natriuretic Peptide Is Processed in the Circulation in a Rat Model
- N-Terminal Pro-Brain Natriuretic Peptide: A Powerful Predictor of Mortality in Hypertension
- Management of Chronic Heart Failure Guided by Individual N-Terminal Pro-B-Type Natriuretic Peptide Targets: Results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) Study
- Biomarkers in Stroke: When Will They Impact Care?
- Processing of Pro-B-Type Natriuretic Peptide: Furin and Corin as Candidate Convertases
- The ROSE (Risk Stratification of Syncope in the Emergency Department) Study
- Acute heart failure: focusing on acute cardiogenic pulmonary oedema
- N-Terminal Pro-B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure: Results From the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) Trial
- Palliative Care in the Treatment of Advanced Heart Failure
- B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective Studies
- Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin: A Report From CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)
- Can Natriuretic Peptides Help Identify Heart Failure Patients for Whom Statins Are Beneficial?
- Are Multiple Biomarker Testing Strategies Ready for Prime Time in Heart Failure?
- Prognostic Value of Biomarkers in Heart Failure: Application of Novel Methods in the Community
- Therapeutic potential of infused cardiac natriuretic peptides in myocardial infarction
- Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence
- Comparison of Midregional Pro-Atrial and B-Type Natriuretic Peptides in Chronic Heart Failure: Influencing Factors, Detection of Left Ventricular Systolic Dysfunction, and Prediction of Death
- Blood Markers for the Prognosis of Ischemic Stroke: A Systematic Review
- Genetic Polymorphisms of the Natriuretic Peptide System in the Pathogenesis of Cardiovascular Disease: What Lies on the Horizon?
- Digoxin Therapy Does Not Improve Outcomes in Patients With Advanced Heart Failure on Contemporary Medical Therapy
- Amino-Terminal Pro-B-Type Natriuretic Peptide as Predictor of Mortality in Patients with Symptomatic Peripheral Arterial Disease: 5-Year Follow-Up Data from the Linz Peripheral Arterial Disease Study
- Detection of Endogenous B-Type Natriuretic Peptide at Very Low Concentrations in Patients With Heart Failure
- Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)
- Timing of Immunoreactive B-Type Natriuretic Peptide Levels and Treatment Delay in Acute Decompensated Heart Failure: An ADHERE (Acute Decompensated Heart Failure National Registry) Analysis
- Natriuretic peptides or psychometric tests? Prognostic markers in congestive heart failure
- Natriuretic Peptides
- Role of brain natriuretic peptide (BNP) in risk stratification of adult syncope
- Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?
- N-Terminal Pro-B-Type Natriuretic Peptide, Vascular Disease Risk, and Cholesterol Reduction Among 20,536 Patients in the MRC/BHF Heart Protection Study
- Gender-Specific Risk Stratification With B-Type Natriuretic Peptide Levels in Patients With Acute Dyspnea: Insights From the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation Study
- Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure
- Natriuretic peptides in the diagnosis and management of heart failure.
- Direct Comparison of B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in a Large Population of Patients with Chronic and Symptomatic Heart Failure: The Valsartan Heart Failure (Val-HeFT) Data
- Collapse query cause: the management of adult syncope in the emergency department
- Novel Snake Venom Ligand Dendroaspis Natriuretic Peptide Is Selective for Natriuretic Peptide Receptor-A in Human Heart: Downregulation of Natriuretic Peptide Receptor-A in Heart Failure
- Assay for Measurement of Intact B-Type Natriuretic Peptide Prohormone in Blood
- Diagnosis and diagnostic testing in primary care
- Dipeptidyl-Peptidase IV Converts Intact B-Type Natriuretic Peptide into Its des-SerPro Form
- Review: B type natriuretic peptide consistently predicts death and cardiovascular events in heart failure
- BNP and amino terminal proBNP assays did not differ for detecting congestive heart failure in the emergency department
- Cardiac impairment or heart failure?
- Prognostic Value of BNP in Patients with Heart Failure